Corrigendum to "Spectrofluorimetric first derivative synchronous approach for determination of olanzapine and samidorphan used for treatment of schizophrenia in pharmaceutical formulations and human plasma" [Spectrochim. Acta A: Mol. Biomol. Spectrosc. 274 (2022) 121105].

Autor: Salem H; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt. Electronic address: hesham.salem@deraya.edu.eg., Samir E; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt., Mazen DZ; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt., Madian H; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt., Elkhateeb AE; Faculty of Pharmacy, Deraya University, New Minia, Egypt., Elaraby M; Faculty of Pharmacy, Deraya University, New Minia, Egypt., Rasekh MI; Faculty of Pharmacy, Deraya University, New Minia, Egypt., Gamal A; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Jazyk: angličtina
Zdroj: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Jun 05; Vol. 314, pp. 124215. Date of Electronic Publication: 2024 Mar 29.
DOI: 10.1016/j.saa.2024.124215
Databáze: MEDLINE
Externí odkaz: